2023-05-11 17:42:48 ET
- Equillium press release ( NASDAQ: EQ ): Q1 GAAP EPS of -$0.11 beats by $0.07 .
- Revenue of $8.9M.
- Research and development (R&D) expenses for the first quarter of 2023 were $9.3 million, compared with $10.8 million for the same period in 2022.
- General and administrative (G&A) expenses for the first quarter of 2023 were $3.7 million, compared with $3.5 million for the same period in 2023.
- Cash, cash equivalents and short-term investments totaled $62.0 million as of March 31, 2023, compared to $71.0 million as of December 31, 2022.
For further details see:
Equillium GAAP EPS of -$0.11 beats by $0.07, revenue of $8.9M